Newronika

About:

Newronika restores brain and body functions with innovative technologies.

Website: http://www.newronika.com

Twitter/X: newronika

Top Investors: European Innovation Council, Omnes Capital, Indaco Venture Partners, Innogest Capital, Atlante Ventures

Description:

Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normal daily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. ​ Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.

Total Funding Amount:

12.6M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Milan, Lombardia, Italy

Founded Date:

2008-01-01

Contact Email:

info(AT)newronika.com

Founders:

Alberto Priori, Lorenzo Rossi

Number of Employees:

11-50

Last Funding Date:

2022-12-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai